This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Transplant Company recently announced that AlloSureis now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 1 "The availability of AlloSure dd-cfDNA for all pediatric heart transplant patients is a major development.
Jon Kobashigawa, MD, of the Smidt Heart Institute at Cedars-Sinai, is an expert in heart transplantation, heart failure, and other complex cardiac conditions. Kobashigawa will also represent the American Society of Transplantation in discussions with government agencies and policymakers about organ transplant legislation. “Dr.
Nature Reviews Cardiology, Published online: 21 May 2024; doi:10.1038/s41569-024-01041-x A study in Nature describes a single-cell-type strategy for vascular cell therapies that involves the artificial transplantation of mitochondria to endothelial cells, which promotes mitophagy and facilitates the formation of functional vessels in ischaemic tissue (..)
New data from the UNOS database presented at NASPGHAN 2024 details characteristics and outcomes of pediatric liver transplant patients receiving machine perfused organs.
In 2024, Boston-based Tufts Medical Center performed 70 adult heart transplants, breaking its 2023 record by nine and setting the New England region record for the second year in a row.
"Vanderbilt Transplant Center sets world record with 174 heart transplants in 2024, including pediatric procedures. Learn more about their achievements and adva
By the end of the study cardiologists performed 10% fewer biopsies in the first year post-transplant and 40% fewer in the second year post-transplant despite an increase in follow-up biopsy rates for dual positives. Hanna , CareDx President and CEO.
Circulation, Volume 150, Issue Suppl_1 , Page A4144084-A4144084, November 12, 2024. Despite being a heart transplantation candidate, she declined revascularization and sought alternative treatments for angina, dyspnea, and daily activity limitations. The patient underwent EECP, consisting of 35 one-hour sessions over seven weeks.
In organ transplantation, an extended criteria donor is defined as having perceived risk factors linked to poor subsequent outcomes, for example, those with age >55 or ischemic times exceeding 4 hours, which sometimes leads to rejection of the donor organ. utilizing the Paragonix SherpaPak CTS (p=0.022).
The third quarterly issue of 2024 reviews early versus late ERCP outcomes post-transplant, the impact of GLP-1RA use on endoscopic management, and the differential diagnosis of seronegative villous atrophy.
The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. Learn more about the highlights from ACC 2024. Presented at: ACC 2024. April 6, 2024. April 6, 2024. Reference: Stone GW. Atlanta, GA.
Getty Images milla1cf Wed, 02/21/2024 - 19:10 February 21, 2024 — Ochsner Children's Hospital , ranked among the top hospitals in the nation for pediatric cardiology and congenital heart surgery, is raising awareness of the need for more pediatric-specific heart devices. Yet, research and innovation in this field has not kept pace.
Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high.
Photo by Cedars-Sinai milla1cf Mon, 06/24/2024 - 20:17 June 24, 2024 — Aakriti Gupta, MD , and Michelle Kittleson, MD, PhD , cardiologists in the Smidt Heart Institute at Cedars-Sinai , have been selected to join the senior editorial team of the Journal of the American College of Cardiology (JACC), effective July 1.
milla1cf Tue, 04/16/2024 - 12:35 April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of Heart Failure. See more details at TCTMD.
Circulation, Volume 150, Issue Suppl_1 , Page A4146828-A4146828, November 12, 2024. Heart transplantation remains a vital treatment for end-stage heart failure, yet the scarcity of suitable donor hearts makes the treatment unavailable to many patients in critical need.
The American College of Cardiology (ACC) held its 73 rd annual scientific session and expo April 6-8, 2024 in Atlanta, Georgia. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. April 6, 2024.
Nature Reviews Cardiology, Published online: 23 January 2024; doi:10.1038/s41569-024-00991-6 Heart valve replacement in newborn babies remains an unsolved problem because currently used heart valve implants do not grow. This lack of implant growth mandates serial re-operations until adult-size valve implants can be fitted.
milla1cf Wed, 05/15/2024 - 08:50 May 15, 2024 — The U.S. 882 Dates Distributed: March 1, 2021 to present Date Initiated by Firm: March 13, 2024 Device Use The HeartMate 3 Left Ventricular Assist System (LVAS) is used to help the heart pump blood when it is not able to do so effectively on its own.
Circulation, Volume 150, Issue Suppl_1 , Page A4123674-A4123674, November 12, 2024. Background:Transplantation arteriosclerosis is one of the major complications for the mid- and long-term survival of recipients with organ transplantation.
Circulation: Cardiovascular Imaging, Volume 17, Issue 1 , Page e015858, January 1, 2024. BACKGROUND:Advanced chronic kidney disease is associated with high cardiovascular risk, even after kidney transplant. years post-transplant. An abnormal MPI result was defined as a total perfusion deficit >5% of the myocardium.
Circulation, Volume 150, Issue Suppl_1 , Page A4146920-A4146920, November 12, 2024. Cox regression results showed that there is an increased risk of mortality in patients who did not receive transfusions before transplant (p<0.0001).Conclusion:While
Image courtesy of Abbott mtaschetta-millane Mon, 04/15/2024 - 09:54 April 15, 2024 — The U.S. 13,883 Date Initiated by Firm: February 19, 2024 Device Use The HeartMate II and HeartMate 3 Left Ventricular Assist Systems (LVAS) are used to help the heart pump blood when it's not able to do so effectively on its own.
The primary outcome was death from any cause, and the secondary outcome included a composite of death, heart transplantation, or ventricular assist device implantation. N Engl J Med 2024; 390:212-220. Long-term outcomes were assessed at the eight highest-enrolling sites. In the RAFT trial, 1798 patients were enrolled by February 2009.
9-11, 2024. Image courtesy: Getty Images christine.book Fri, 02/02/2024 - 11:35 February 2, 2024 — The American College of Cardiology ’s Cardiac Oncology Conference, “ Advancing the Cardiovascular Care of the Oncology Patient ,” will be held in person at the Heart House in Washington, D.C.,
Publication date: Available online 23 July 2024 Source: The American Journal of Cardiology Author(s): Giulio Cacioli, Michele Ciabatti, Ernesto Cristiano, Claudia Notari, Ilaria Papisca, Giada Distefano, Giovanni Menafra, Paola Lilla Della Monica, Mariano Antonio Feccia, Amedeo Pergolini, Viviana Maestrini, Fabio Sbaraglia, Federico Ranocchi, Francesco (..)
Photo courtesy of The Ohio State University Wexner Medical Center milla1cf Thu, 02/22/2024 - 13:45 February 22, 2024 — About 1 in 250 Americans have dilated cardiomyopathy (DCM), a type of inherited heart muscle disease that can cause heart failure at a young age. heart failure/heart transplant programs that contributed to the study.
milla1cf Mon, 01/08/2024 - 14:35 January 8, 2024 — University Hospitals (UH) Harrington Heart & Vascular Institute recently became the first center in the world to implant Medtronic’s Penditure Left Atrial Appendage (LAA) Exclusion System through a minimally invasive approach during a mitral valve repair procedure.
Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. , The CMS coverage approval is supported by the scientific rigor of the protocol design and the results from the interim data from the CardiAMP Heart Failure Trial recently presented at the Technology and Heart Failure Therapeutics 2024 annual meeting.
Publication date: Available online 27 August 2024 Source: The American Journal of Cardiology Author(s): Rishabh Tandon, Dzhalal Agakishiev, Rebecca L. Freese, Julie Thompson, Prabhjot S.
Publication date: Available online 6 July 2024 Source: The American Journal of Cardiology Author(s): Jacob Agronin, Meredith Brown, Hannah Calvelli, Huaqing Zhao, Val Rakita, Yoshiya Toyoda, Mohammed Abul Kashem
Cardiac transplantation, the only option for many patients, is severely restricted by the limited availability of donor hearts. The research is funded by a four-year, $7.8 Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden.
Publication date: Available online 28 November 2024 Source: The American Journal of Cardiology Author(s): David Grundmann, Janina Neubarth-Mayer, Christoph Müller, Finn Becker, Daniel Reichart, Konstantin Stark, Ulrich Grabmaier, Simon Deseive, Konstantinos D.
We carried out a prospective national specialist nurses in organ donation (SNOD) audit of UK donor offers between 20 August and 31 November 2022, and a prospective national recipient transplant centre audit of all donor offers between 22 September and 19 December 2022. hours (interquartile range [IQR] 13.9–33.2).
Publication date: Available online 31 July 2024 Source: The American Journal of Cardiology Author(s): Shafaqat Ali, Manoj Kumar, Sanchit Duhan, Yehya Khlidj, Hafiz Muhammad Waqar Younas, Faryal Farooq, Bijeta Keisham, Pramod Kumar Ponna, Michael Sewell, Vijaywant Brar, Steven R Bailey, Timir K Paul, Tarek Helmy
Circulation, Volume 150, Issue Suppl_1 , Page A4146823-A4146823, November 12, 2024. Heart transplant rates were low but increased slightly in 2020 for patients without CHD, with DV and SV CHD patients showing fluctuating rates peaking in 2018 and 2019, then declining in 2020. Patients without CHD were older (mean age 71.5
Stroke, Volume 55, Issue Suppl_1 , Page ATP42-ATP42, February 1, 2024. Stem cell transplantation enhances stroke recovery. While promising, the treatment efficacy of stem cell transplantation is restricted by inadequate stem cell survival and insufficient trophic factor release at the stroke site.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content